The major growth driver identified in the biochemistry analyzers market is growing demand for these analyzers in hospitals, and pharmaceutical companies. With the rising numbers of patients with kidney diseases, liver failures, and diabetes, demand for analysis of blood biochemistry parameters of these patients is also increasing. As a result, demand for these analyzers has also been growing.
On the basis of both value and volume, North America dominated the market in 2017.
Growth of the biochemistry analyzers market is hindered by factors such as its complex system integration is complex and high upfront cost. High upfront cost has dented its attractiveness among price sensitive customers in countries from Asia-Pacific.
From supply side, many of the producers of biochemistry analyzers are located in this region and they have strong distribution channel penetration across hospitals, diagnostics centers, pharmaceutical and biotechnology companies, and academic research institutes.
Request to Get the Sample Report : https://www.psmarketresearch.com/market-analysis/biochemistry-analyzers-market/report-sample
Some of the major players operating in the global biochemistry analyzers marketare Abbott, Siemens AG, Thermo Fisher Scientific, HORIBA, Ltd., F. Hoffmann-La Roche Ltd, Beckman Coulter Inc., Hologic, Inc., Danaher Corporation, Meril Life Sciences Pvt. Ltd., and Randox Laboratories Ltd.
Hello, my name is Jack Sparrow. I'm a 50 year old self-employed Pirate from the Caribbean.
No comments:
Post a Comment